Shareholding disclosure

Credit Suisse Group AG

Declared position

6.06%

Threshold

Crossed upwards

Timeline

Published

22.02.2017

Transaction

14.02.2017

Voting rights breakdown

Voting rights acquired6.06%

Voting rights sold0.11%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAH2H00022

Beneficial owner

Credit Suisse Group AG

Declared address

Credit Suisse Group AG, Zürich

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Credit Suisse Group AG

Basilea Pharmaceutica AG, Allschwil22.02.2017TAH2H00022

Disclosure summary

Credit Suisse Group AG disclosed a holding in Basilea Pharmaceutica AG, Allschwil on the acquisition side, published by SIX Exchange Regulation on 22.02.2017, at 6.06% of voting rights. Notice category: Single shareholder.

Disclosed position

6.06%

Voting rights acquired

Voting rights acquired6.06%

Voting rights sold0.11%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Credit Suisse Group AG disclosed a holding in Basilea Pharmaceutica AG, Allschwil, published on 22.02.2017.

Publication date22.02.2017

Transaction date14.02.2017

Issuing companyBasilea Pharmaceutica AG, Allschwil

Beneficial ownerCredit Suisse Group AG

Declared addressCredit Suisse Group AG, Zürich

CategorySingle shareholder

Voting rights acquired6.06%

Voting rights sold0.11%

Below threshold0%

ExchangeXSWX

Notification IDTAH2H00022

Commercial register

CHE-105.884.494

Struck off the register · 14.06.2023

Zefix record

Source: SIX Exchange Regulation · Publication date: 22.02.2017

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open